EUVIMEDEUVIMED entdecken
Crossref

Galectin-3 as a potential biomarker of metabolic disorders and cardiovascular remodeling in patients with hypertension and type 2 diabetes

Lesya Bobronnikova

Vessel Plus · 2017

DOI: 10.20517/2574-1209.2016.10 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vessel Plus, 2017. Verfasst von Lesya Bobronnikova. Die Arbeit wurde bisher 13-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vessel Plus is an open acccess journal, which publishes articles related to vascular diseases, including acute respiratory distress syndrome, aneurysm, atherosclerosis, hypertension, stroke, peripheral vascular or pulmonary vascular diseases, etc.

Zitieren

APA

Bobronnikova, L. (2017). Galectin-3 as a potential biomarker of metabolic disorders and cardiovascular remodeling in patients with hypertension and type 2 diabetes. Vessel Plus. https://doi.org/10.20517/2574-1209.2016.10

Vancouver

Bobronnikova L. Galectin-3 as a potential biomarker of metabolic disorders and cardiovascular remodeling in patients with hypertension and type 2 diabetes. Vessel Plus. 2017. doi:10.20517/2574-1209.2016.10

BibTeX
@article{Bobronnikova2017,
  author = {Bobronnikova, Lesya},
  title = {Galectin-3 as a potential biomarker of metabolic disorders and cardiovascular remodeling in patients with hypertension and type 2 diabetes},
  journal = {Vessel Plus},
  year = {2017},
  doi = {10.20517/2574-1209.2016.10}
}
Kostenlos starten →